Starpharma Holdings: Innovating Dendrimer Tech to Transform Oncology & Infectious Disease Markets
Starpharma Holdings, a leading biopharma firm, pioneers dendrimer‑based cancer and infectious disease therapies, driving innovation amid financial challenges and a 0.5 AUD ASX listing.
2 minutes to read
